Literature DB >> 5112201

Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates.

R Snyderman, J K Phillips, S E Mergenhagen.   

Abstract

The importance of C5 in the generation of complement (C)-dependent chemotactic activity in vitro is well recognized. However, the actual role C5 may play in the accumulation of polymorphonuclear leukocytes (PMN) at inflammatory sites in vivo has not been established. Injection of glycogen or endotoxin into the peritoneal cavities of guinea pigs resulted, shortly thereafter, in the local accumulation of PMN. Preceding the influx of leukocytes, the peritoneal fluid became chemotactic for rabbit PMN in vitro. The majority of this activity could be attributed to a cleavage product of C5 (C5a). Similarly, injection of endotoxin into the peritoneal cavity of C5-normal mice resulted in the generation of a chemotactic factor for mouse PMN which was followed by the accumulation of PMN in the peritoneal fluid. In contrast, injection of endotoxin into the peritoneal cavity of C5-deficient mice resulted in the generation of virtually no detectable chemotactic activity and a markedly depressed accumulation of PMN during the first 24 hr after injection. The data suggest that C5 plays an important role in the early phases of PMN accumulation in response to inflammatory stimuli. The rapid accumulation of PMN in response to an inflammatory stimulus such as bacterial endotoxin would be expected to be a major factor in host defense against proliferation and dissemination of infectious agents.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5112201      PMCID: PMC2139022          DOI: 10.1084/jem.134.5.1131

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

Review 1.  Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response.

Authors:  O D Ratnoff
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

Review 2.  Chemistry and reaction mechanisms of complement.

Authors:  H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

Review 3.  Significance of complement to the mechanism of action of endotoxin.

Authors:  S E Mergenhagen; R Snyderman; H Gewurz; H S Shin
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

4.  A chemotactic factor for mononuclear leukocytes.

Authors:  R Snyderman; H S Shin; M H Hausman
Journal:  Proc Soc Exp Biol Med       Date:  1971-11

5.  Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.

Authors:  R Snyderman; H Gewurz; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-08-01       Impact factor: 14.307

6.  Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro.

Authors:  J G HIRSCH; A B CHURCH
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

7.  Role of complement during experimental Candida infection in mice.

Authors:  R Morelli; L T Rosenberg
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

8.  Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor.

Authors:  R Snyderman; J Phillips; S E Mergenhagen
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

9.  The role of complement in resistance to endogenous and exogenous infection with a common mouse pathogen, Corynebacterium kutscheri.

Authors:  L D Caren; L T Rosenberg
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  THE ROLE OF COMPLEMENT IN THE PASSIVE CUTANEOUS REACTION OF MICE.

Authors:  S BEN-EFRAIM; B CINADER
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

View more
  46 in total

1.  Comparison of subcutaneous and intraperitoneal staphylococcal infections in normal and complement-deficient mice.

Authors:  C S Easmon; A A Glynn
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

2.  Analysis of macrophage bactericidal function in genetically resistant and susceptible mice by using the temperature-sensitive mutant of Listeria monocytogenes.

Authors:  F Gervais; A Morris-Hooke; T A Tran; E Skamene
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

3.  Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.

Authors:  H E Jasin
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

4.  Paraquat-induced neutrophil alveolitis: reduction of the inflammatory response by pretreatment with endotoxin and hyperoxia.

Authors:  W J Martin; D M Howard
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 5.  Molecular aspects of the phagocytosis resistance of group A streptococci.

Authors:  B N Manjula
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

6.  Opsonins in normal mouse serum for the phagocytic killing of Proteus mirabilis by murine neutrophils.

Authors:  J J Finlay-Jones; N L Hill; M F Nulsen; H Pruul; P J McDonald
Journal:  Br J Exp Pathol       Date:  1984-12

7.  Role of complement in the expression of delayed-type hypersensitivity in rats: studies with cobra venom factor.

Authors:  T W Jungi; D D McGregor
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  The chemotactic response of tumor cells. A model for cancer metastasis.

Authors:  W C Lam; E J Delikatny; F W Orr; J Wass; J Varani; P A Ward
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

9.  The magnitude of macrophage inflammatory response does not directly depend on ability of bone marrow cells to respond to interleukin-3 in mice of different strains.

Authors:  G N Pozzulo; E Skamene; F Gervais
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

10.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.